Atlas Trials

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Clinical trial NCT06265883 · COMPLETED

Trial details

NCT number
NCT06265883
Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma Non-resectable
Start date
2019-07-01
Primary completion
2022-12-31
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.